Admera Health

Admera Health is a privately held, revenue-generating diagnostics and research services company founded in 2012. It has established itself as a specialized partner in RNA and multi-omics, leveraging a broad technology platform and a scientist-to-scientist service model to support discovery research. The company's value proposition is built on high data quality (99.9% pass-through rate), rapid turnaround, US-based operations, and support for over 19,000 peer-reviewed publications, positioning it as a trusted vendor for complex genomic projects.

Integrated multi-omics service platform utilizing over 30 technology partnerships (e.g., 10x Genomics, PacBio, Parse Biosciences) for RNA-seq, single-cell, spatial, long-read, WGS, WES, and methyl-seq, supported by a CAP-accredited/CLIA-certified lab and proprietary bioinformatics pipelines.

Admera competes in a crowded field including large, diversified CROs (e.g., LabCorp, IQVIA), global genomics service giants (e.g., Novogene, Azenta), and academic core facilities. It differentiates through deep RNA expertise, a multi-omic integrated offering, and rigorous quality standards from its CAP/CLIA lab.